Is Fresenius Medical Care AG & Co. KGaA (FMS) a Buy, Sell, or Hold?
NYSE : FMS
Fresenius Medical Care AG & Co. KGaA — Institutional Ownership
$23.89 USD
-$0.12 (-0.5%)
- Volume
- 1.35M
- Average Volume
- 780.67K
- Market Capitalization
- $12.83B
- P/E Ratio
- 12.44
- Dividend Yield
- 3.61%
- Price Target
- $22.45
- Year High
- $27.64
- Year Low
- $20.02
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.45
- Current Ratio
- $1.20
Institutional Ownership Summary
Institutional Ownership %
0.64%
Investors Holding
97
change: -126.0 | last: 223
Increased Positions
53
change: -79.0 | last: 132
Reduced Positions
17
change: -31.0 | last: 48
New Positions
20
change: -23.0 | last: 43
Sold Positions
142
change: 103.0 | last: 39
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: -428.5714 | last: 4.2857
Total Invested
79.18M
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-01-09 | Fresenius Medical Care AG | 18.31M | 9.50% |
| 2026-01-09 | Fresenius Medical Care Holdings, Inc. | 18.31M | 9.50% |
| 2025-10-16 | Fresenius Medical Care AG | 18.31M | 9.90% |
| 2025-03-10 | Fresenius SE & Co. KGaA | 83.78M | 28.60% |
| 2025-03-06 | Fresenius SE & Co. KGaA | 94.38M | 32.20% |
| 2025-02-14 | HARRIS ASSOCIATES L P | 11.72M | 3.90% |
| 2023-02-14 | PAGE 2 OF 4 PAGES | 14.12M | 5.40% |
| 2023-02-14 | PAGE 2 OF 4 PAGES | 14.12M | 5.40% |
| 2016-01-28 | T. ROWE PRICE ASSOCIATES, INC. | 3.22M | 9.30% |
| 2012-05-09 | (1) BlackRock, Inc. | 13.28M | 4.42% |
| 2012-03-01 | Fresenius SE & Co. KGaA | 94.38M | 31.40% |
| 2012-02-16 | Fresenius SE & Co. KGaA | 94M | 31.40% |
| 2012-02-09 | (1) BlackRock, Inc. | 15.16M | 5.05% |
FMS Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $20.27 | 582.38M | $11.81B | $1.6B | $10.8B | $21B |
| 2024-12-31 | $21.86 | 587.88M | $12.85B | $1.18B | $11B | $22.68B |
| 2023-12-31 | $19.22 | 587.06M | $11.29B | $1.4B | $12.08B | $21.96B |
| 2022-12-31 | $15.26 | 1.17B | $17.9B | $1.27B | $13.21B | $29.84B |
| 2021-12-31 | $28.55 | 1.17B | $33.45B | $1.48B | $13.32B | $45.29B |
| 2020-12-31 | $34.00 | 888.24M | $30.2B | $1.08B | $12.38B | $41.5B |
| 2019-12-31 | $32.84 | 888.24M | $29.17B | $1.01B | $13.82B | $41.98B |
| 2018-12-31 | $28.24 | 614.55M | $17.36B | $2.15B | $7.58B | $22.79B |
| 2017-12-31 | $43.60 | 615.28M | $26.83B | $978.11M | $7.52B | $33.37B |
| 2016-12-31 | $40.08 | 613.39M | $24.59B | $708.88M | $8.13B | $32.01B |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19.79 | 550.49M | $10.89B | -$ | -$ | $10.89B |
| 2026-03-31 | $19.52 | 550.49M | $10.74B | $1.24B | $11.03B | $20.53B |
| 2025-12-31 | $20.27 | 571.81M | $11.59B | $1.6B | $10.8B | $20.79B |
| 2025-09-30 | $22.43 | 584.67M | $13.12B | $1.26B | $10.47B | $22.33B |
| 2025-06-30 | $24.24 | 586.83M | $14.23B | $1.72B | $11.02B | $23.54B |
| 2025-03-31 | $23.01 | 586.83M | $13.5B | $1.07B | $10.84B | $23.27B |
| 2024-12-31 | $21.86 | 1.17B | $25.66B | $1.18B | $11B | $35.48B |
| 2024-09-30 | $19.13 | 1.17B | $22.45B | $1.37B | $11.23B | $32.3B |
| 2024-06-30 | $17.86 | 1.17B | $20.96B | $1.09B | $11.78B | $31.65B |
| 2024-03-31 | $17.76 | 1.17B | $20.85B | $1.15B | $12.06B | $31.76B |
| 2023-12-31 | $19.22 | 880.02M | $16.92B | $1.4B | $12.08B | $27.59B |
| 2023-09-30 | $20.37 | 880.02M | $17.92B | $1.55B | $12.97B | $29.34B |